Table 1.
General characteristics of the data set.
|
|
Cephalosporin | TZPa | TMP-SMXb | Fluoroquinolone | Carbapenem |
| Samples, n | 3535 | 737 | 708 | 1582 | 1365 |
| Admissions, n | 396 | 366 | 374 | 571 | 392 |
| Patients, n | 390 | 360 | 368 | 557 | 386 |
| Resistance, n (%) | 1492 (42.2) | 169 (22.9) | 281 (39.7) | 1014 (64.1) | 142 (10.4) |
| Age (years), mean (SD) | 71.5 (14.4) | 71.4 (14.4) | 71.4 (14.4) | 71.9 (14.4) | 71.7 (14.3) |
| Female, n (%) | 2597 (73.5) | 523 (71) | 507 (71.6) | 1013 (64) | 994 (72.8) |
| Most common bacteria (Escherichia coli), n (%) | 1650 (46.7) | 312 (42.3) | 331 (46.7) | 349 (22) | 624 (45.7) |
| Second-most common bacteria (Klebsiella pneumoniae), n (%) | 556 (15.7) | 109 (14.8) | 111 (15.7) | 305 (19.3)c | 220 (16.1) |
| Third-most common bacteria (Pseudomonas aeruginosa), n (%) | 168 (4.7) | 69 (9.4) | 21 (3)d | 180 (11.4)e | 83 (6.1) |
aTZP: piperacillin-tazobactam.
bTMP-SMX: trimethoprim-sulfamethoxazole.
cThe isolated bacterial specimen is Enterococcus faecium.
dThe isolated bacterial specimen is Citrobacter freundii.
eThe isolated bacterial specimen is Enterococcus faecalis.